Asia-Pacific Protein Expression Market to Grow with a CAGR of 14.37% through 2030
The growing
prevalence
of chronic diseases like cancer, diabetes, and autoimmune disorders is expected
to drive the Asia-Pacific Protein Expression Market growth in the forecast
period, 2026-2030.
According to
TechSci Research report, “Asia-Pacific Protein Expression Market – By Country, Competition Forecast & Opportunities, 2030”,
the Asia-Pacific Protein Expression Market stood at USD 540.21 million in 2024
and is anticipated to grow with a CAGR of 14.37% in
the forecast period, 2026-2030. The Asia-Pacific protein expression market is
experiencing significant growth, driven by the increasing demand for biologics
and the rising prevalence of chronic diseases such as cancer, diabetes, and
autoimmune disorders.
As the region’s
healthcare infrastructure improves and access to advanced medical treatments
expands, the need for high-quality therapeutic proteins has surged. Protein
expression technologies, which enable the production of complex proteins for
use in therapeutics, diagnostics, and research, are essential for meeting this
demand. Countries such as China, India, and Japan are leading the way in
adopting innovative protein expression systems, with advancements in gene
editing technologies, recombinant DNA technology, and protein purification
methods further driving market growth. As biopharmaceutical companies in the
region ramp up the development of biologics and biosimilars, the demand for
protein expression tools and services continues to increase, fostering a
dynamic and competitive market landscape.
In addition to
the demand for therapeutic proteins, the Asia-Pacific region is seeing
increased investment in research and development (R&D) within
biotechnology, further bolstering the protein expression market. Government
initiatives, as well as partnerships between academic institutions, biotech
startups, and pharmaceutical giants, are accelerating innovation in protein
production and expression platforms. As a result, new expression systems, such
as cell-free protein expression and advancements in mammalian cell culture, are
becoming more widely adopted. Moreover, the region's expanding pharmaceutical
manufacturing capabilities, particularly in China and India, are positioning
Asia-Pacific as a hub for protein expression technologies. This growth is further
fueled by the increasing focus on personalized medicine, which requires
tailored protein therapeutics, and the shift toward producing biosimilars as
patent expirations for blockbuster biologics occur. Consequently, the protein
expression market in Asia-Pacific is expected to continue its upward
trajectory, offering new opportunities for biopharmaceutical companies,
researchers, and healthcare providers across the region.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on "Asia-Pacific Protein Expression Market”
The Asia-Pacific
Protein Expression Market is segmented into application, product, end user, country, and company.
Based on product,
the kits and reagents category is showing the fastest growth in the Asia-Pacific
Protein Expression market, driven by the increasing demand for research and
development in biotechnology and pharmaceutical industries. Protein expression
kits and reagents are essential tools used for the production, purification,
and analysis of proteins, and their widespread adoption is crucial for
advancing biopharmaceutical manufacturing, diagnostic applications, and basic
scientific research. The growing focus on drug discovery, personalized
medicine, and the development of biologics, including monoclonal antibodies and
therapeutic proteins, is fueling the demand for high-quality kits and reagents.
These products enable researchers and manufacturers to streamline their
processes, improve yields, and achieve greater precision in protein expression,
thus driving their rapid market growth.
Based on country, Japan is
expected to show significant growth in the Asia-Pacific protein expression
market over the forecast period, driven by its advanced healthcare
infrastructure, strong pharmaceutical industry, and increasing demand for
biologics and biosimilars. As one of the leading countries in biotechnology and
pharmaceutical research, Japan is heavily investing in innovative technologies
and expanding its biomanufacturing capabilities. The growing focus on
personalized medicine, along with the country’s well-established regulatory
frameworks for biopharmaceuticals, is accelerating the adoption of protein
expression technologies. These technologies are essential for producing
therapeutic proteins used in treating various diseases such as cancer,
diabetes, and autoimmune disorders.
Major companies
operating in Asia-Pacific Protein Expression Market are:
- GenCefe
Co., Ltd.
- Takara Bio Inc.
- Merck KGaA
- Charles River Laboratories
- Agilent Technologies Inc.
- GeNext Genomics
- Thermo Fisher Scientific Inc.
- WuXi Biologics
- Ajinomoto Bio-Pharma Services
- Domainex
Download Free Sample Report
Customers can
also request for 10% free customization on this report
"The
growing demand for biologics and biosimilars, along with the rapid advancements
in biotechnology, is significantly driving the growth of the protein expression
market in the Asia-Pacific region. The increasing adoption of cutting-edge
technologies such as recombinant DNA technology, gene editing, and cell-free
protein expression systems is enhancing the precision and efficiency of protein
production. Increasing awareness among healthcare providers about the potential
of biologic treatments and the growth of personalized medicine are further
contributing to market demand. With continued investment in R&D and
government initiatives supporting the biotechnology sector, the Asia-Pacific
protein expression market is poised for significant growth, making it a key
player in the global healthcare landscape. These trends are expected to reshape
the protein expression market in the region, making it more innovative,
accessible, and capable of addressing the diverse needs of patients and
healthcare providers alike," said Mr. Karan Chechi, Research Director of TechSci Research, a research-focused management consulting firm.
“Asia-Pacific
Protein Expression Market By Application
(Biopharmaceutical Manufacturing, Research and Development, Industrial Usage),
By Product (Kits and Reagents, Expression Vectors, Competent Cells, Plastic
Consumables and Accessories), By End User (Biopharmaceutical and Biotech
Companies, CRO and CDMO, Academic & Research Institutes, Others), By
Country, Competition, Forecast & Opportunities, 2020-2030F”, has evaluated
the future growth potential of Global Asia-Pacific Protein Expression Market
and provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Asia-Pacific Protein Expression Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: sales@techsciresearch.com
Website: www.techsciresearch.com